Tabula Rasa HealthCare Inc.

NAS: TRHC

GO
/marketstate/country/us

After Hours

 --Real time quotes

May 12, 2021, 4:18 p.m.

/zigman2/quotes/201220766/composite

$

43.04

Change

+0.46 +1.07%

Volume

Volume 11,642

Real time quotes

/zigman2/quotes/201220766/composite

Previous close

$ 43.37

$ 42.58

Change

-0.79 -1.82%

Day low

Day high

$42.09

$44.28

Open

52 week low

52 week high

$30.12

$69.31

Open

Company Description

Tabula Rasa Healthcare, Inc. engages in the development of pharmaceutical software that optimizes medication regimens. It provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitali...

Tabula Rasa Healthcare, Inc. engages in the development of pharmaceutical software that optimizes medication regimens. It provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, healthcare costs and manage risk. The firm offers cloud-based software applications, including EireneRx and MedWise Advisor. The company was founded by Calvin H. Knowlton and Orsula V. Knowlton in April 2009 and is headquartered in Moorestown, NJ.

Valuation

Price to Sales Ratio

3.14

Price to Book Ratio

6.10

Price to Cash Flow Ratio

193.98

Enterprise Value to Sales

4.03

Total Debt to Enterprise Value

0.24

Efficiency

Revenue/Employee

184,151.00

Income Per Employee

-50,165.00

Receivables Turnover

7.88

Total Asset Turnover

0.59

Liquidity

Current Ratio

1.29

Quick Ratio

1.23

Cash Ratio

0.40

Profitability

Gross Margin

15.94

Operating Margin

-18.87

Pretax Margin

-28.98

Net Margin

-27.24

Return on Assets

-16.08

Return on Equity

-45.73

Return on Total Capital

-12.51

Return on Invested Capital

-18.59

Capital Structure

Total Debt to Total Equity

172.51

Total Debt to Total Capital

63.30

Total Debt to Total Assets

56.51

Long-Term Debt to Equity

160.01

Long-Term Debt to Total Capital

58.72

Officers and Executives

Name Age Officer Since Title
Dr. Calvin H. Knowlton 70 2009 Chairman & Chief Executive Officer
Dr. Orsula V. Knowlton 52 2009 President, Director & Chief Marketing Officer
Mr. Michael Greenhalgh - 2014 Chief Operating Officer
Mr. Brian W. Adams 39 2011 Chief Financial Officer
Mr. Bob Sullivan - 2020 Chief Technology Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/27/2021 Andrea C. Speers
Chief Accounting Officer
2,060   Award at $0 per share. 0
04/19/2021 Orsula V. Knowlton
Chief Executive Officer; Director
649   Disposition at $43.61 per share. 28,302
04/19/2021 Orsula V. Knowlton
Chief Executive Officer; Director
7,351   Disposition at $42.96 per share. 315,798
04/14/2021 Calvin H. Knowlton
President; Director
738   Derivative/Non-derivative trans. at $15.16 per share. 11,188
04/14/2021 Calvin H. Knowlton
President; Director
738   Derivative/Non-derivative trans. at $15.16 per share. 11,188
03/11/2021 Orsula V. Knowlton
Chief Executive Officer; Director
972   Disposition at $44.71 per share. 43,458
03/11/2021 Orsula V. Knowlton
Chief Executive Officer; Director
1,254   Disposition at $43.88 per share. 55,025
03/11/2021 Orsula V. Knowlton
Chief Executive Officer; Director
3,765   Disposition at $43.03 per share. 162,007
03/11/2021 Orsula V. Knowlton
Chief Executive Officer; Director
1,200   Disposition at $41.7 per share. 50,040
03/11/2021 Orsula V. Knowlton
Chief Executive Officer; Director
809   Disposition at $40.55 per share. 32,804
03/11/2021 Andrea C. Speers
Chief Accounting Officer
6,218   274,462
03/11/2021 Andrea C. Speers
Chief Accounting Officer
26,612   Derivative/Non-derivative trans. at $44.14 per share. 1,174,653
03/01/2021 Michael J. Purcell
Director
481   Award at $0 per share. 0
03/01/2021 A. Gordon Tunstall
Director
635   Award at $0 per share. 0
03/01/2021 Samira Kanaan Beckwith
Director
2,577   Derivative/Non-derivative trans. at $1.32 per share. 3,401
02/17/2021 Calvin H. Knowlton
President; Director
2,215   Disposition at $49.72 per share. 110,129
02/17/2021 Calvin H. Knowlton
President; Director
10,925   Disposition at $48.8 per share. 533,140
02/17/2021 Calvin H. Knowlton
President; Director
10,860   Disposition at $47.85 per share. 519,651
02/17/2021 Calvin H. Knowlton
President; Director
2,215   Disposition at $49.72 per share. 110,129
02/17/2021 Calvin H. Knowlton
President; Director
10,925   Disposition at $48.8 per share. 533,140
02/17/2021 Calvin H. Knowlton
President; Director
10,860   Disposition at $47.85 per share. 519,651
02/10/2021 A. Gordon Tunstall
Director
1,000   Disposition at $57 per share. 57,000
02/10/2021 A. Gordon Tunstall
Director
1,000   Derivative/Non-derivative trans. at $1.56 per share. 1,560
02/08/2021 Orsula V. Knowlton
Chief Executive Officer; Director
731   Disposition at $57.49 per share. 42,025
02/08/2021 Orsula V. Knowlton
Chief Executive Officer; Director
1,160   Disposition at $56.15 per share. 65,134
02/08/2021 Orsula V. Knowlton
Chief Executive Officer; Director
1,100   Disposition at $55.27 per share. 60,797
02/08/2021 Orsula V. Knowlton
Chief Executive Officer; Director
1,330   Disposition at $54.09 per share. 71,939
02/08/2021 Orsula V. Knowlton
Chief Executive Officer; Director
2,903   Disposition at $53.26 per share. 154,613
02/08/2021 Orsula V. Knowlton
Chief Executive Officer; Director
776   Disposition at $52.15 per share. 40,468
01/29/2021 Calvin H. Knowlton
President; Director
75,000   Award at $0 per share. 0
01/29/2021 Calvin H. Knowlton
President; Director
75,000   Award at $0 per share. 0
01/29/2021 Brian W. Adams
Chief Financial Officer
28,125   Award at $0 per share. 0
01/29/2021 Michael Greenhalgh
Chief Operating Officer
28,125   Award at $0 per share. 0
01/29/2021 Andrea C. Speers
Chief Accounting Officer
14,075   Award at $0 per share. 0
01/27/2021 Brian W. Adams
Chief Financial Officer
12,000   Disposition at $60 per share. 720,000
01/27/2021 Michael Greenhalgh
Chief Operating Officer
16,000   Disposition at $60 per share. 960,000
01/27/2021 Brian W. Adams
Chief Financial Officer
12,000   Derivative/Non-derivative trans. at $3.11 per share. 37,320
01/27/2021 Michael Greenhalgh
Chief Operating Officer
16,000   Derivative/Non-derivative trans. at $3.11 per share. 49,760
/news/latest/company/us/trhc

MarketWatch News on TRHC

  1. Tabula Rasa HealthCare downgraded to hold from buy at Truist

    9:28 a.m. March 1, 2021

    - Tomi Kilgore

  2. Tabula Rasa HealthCare downgraded to hold from buy at Stifel Nicolaus

    8:32 a.m. Jan. 15, 2021

    - Tomi Kilgore

  3. Tabula Rasa stock price target cut to $55 from $65 at Benchmark

    7:12 a.m. Nov. 4, 2020

    - Tomi Kilgore

  4. Tabula Rasa Healthcare price target down to $65 from $75 at Benchmark, stock rated buy

    8:09 a.m. Oct. 2, 2020

    - Tonya Garcia

  5. Tabula Rasa HealthCare stock price target cut to $75 from $84 at Benchmark

    6:20 a.m. Aug. 5, 2020

    - Tomi Kilgore

  6. Tabula Rasa HealthCare initiated as buy at SunTrust Robinson Humphrey

    6:57 a.m. July 2, 2020

    - Ciara Linnane

  7. Tabula Rasa HealthCare assigned $72 price target by SunTrust Robinson Humphrey

    6:58 a.m. July 2, 2020

    - Ciara Linnane

  8. Top stock picks for 2020: Standout small companies

    11:42 p.m. Dec. 12, 2019

    - Philip van Doorn

  9. Tabula Rasa Healthcare stock price target raised to $90 from $85 at Benchmark

    9:11 a.m. March 6, 2019

    - Tomi Kilgore

  10. Tabula Rasa HealthCare started at buy with $85 stock price target at Benchmark

    9:21 a.m. Jan. 8, 2019

    - Tomi Kilgore

  11. The best and worst stocks of 2018

    10:27 a.m. Jan. 3, 2019

    - Philip van Doorn

  12. Tabula Rasa Healthcare started at outperform with $35 stock price target at Oppenheimer

    9:28 a.m. Dec. 19, 2017

    - Tomi Kilgore

  13. Tabula Rasa Healthcare started at overweight with $18 stock price target at Piper Jaffray

    9:17 a.m. Oct. 24, 2016

    - Tomi Kilgore

  14. Tabula Rasa Healthcare started at buy with $17 stock price target at Stifel Nicolaus

    7:15 a.m. Oct. 24, 2016

    - Tomi Kilgore

  15. Tabula Rasa Healthcare started at outperform with $17 stock price target at RW Baird

    6:54 a.m. Oct. 24, 2016

    - Tomi Kilgore

/news/nonmarketwatch/company/us/trhc

Other News on TRHC

  1. Tabula Rasa HealthCare rallies on Q1 estimates beat

    1:04 p.m. May 7, 2021

    - Seeking Alpha

  2. 10-Q: TABULA RASA HEALTHCARE, INC.

    10:52 a.m. May 7, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  3. 10-K: TABULA RASA HEALTHCARE, INC.

    10:17 a.m. Feb. 26, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  4. Tabula Rasa cut to neutral from overweight at Cantor Fitzgerald

    1:47 p.m. Feb. 24, 2021

    - Seeking Alpha

  5. Notable earnings after Tuesday's close

    6:35 p.m. Feb. 22, 2021

    - Seeking Alpha

  6. Tabula Rasa HealthCare's DoseMeRx partners with Physiomics

    11:14 a.m. Dec. 17, 2020

    - Seeking Alpha

  7. CPSI vs. TRHC: Which Stock Is the Better Value Option?

    12:40 p.m. Nov. 9, 2020

    - Zacks.com

  8. 10-Q: TABULA RASA HEALTHCARE, INC.

    7:15 a.m. Nov. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. BIIB, XPEV, CXW and PVAC among midday movers

    1:40 p.m. Nov. 4, 2020

    - Seeking Alpha

  10. Loading more headlines...

At a Glance

Tabula Rasa Healthcare, Inc.

228 Strawbridge Drive

Suite 100

Moorestown, New Jersey 08057-3124

Phone

1 8666482767

Industry

Computer Services

Sector

Business/Consumer Services

Fiscal Year-end

12/2021

Revenue

$297.22M

Net Income

$-80.97M

2020 Sales Growth

4.4%

Employees

1,614

/news/pressrelease/company/us/trhc

Press Releases on TRHC

  1. Tabula Rasa Healthcare, Inc. to Host Earnings Call

    6:45 a.m. May 7, 2021

    - ACCESSWIRE

  2. Tabula Rasa HealthCare Reports First Quarter 2021 Results

    4:30 p.m. May 6, 2021

    - PR Newswire - PRF

  3. Tuesday's ETF with Unusual Volume: IHF

    2:30 p.m. April 6, 2021

    - MarketNewsVideo.com

  4. TRHC's CareKinesis Celebrates 10 Years Serving PACE Market

    8:00 a.m. March 24, 2021

    - PR Newswire - PRF

  5. Tabula Rasa Healthcare, Inc. to Host Earnings Call

    6:31 a.m. Feb. 24, 2021

    - ACCESSWIRE

  6. Loading more headlines...
Link to MarketWatch's Slice.